Tran T, Taylor S E, Hardidge A, Findakly D, Aminian P, Elliott R A
Pharmacy Department, Austin Health, Heidelberg, VIC, Australia.
Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia.
J Clin Pharm Ther. 2017 Oct;42(5):567-572. doi: 10.1111/jcpt.12540. Epub 2017 May 5.
Overprescribing of oxycodone is a contributor to the epidemic of prescription opioid misuse and deaths. Practice models to optimize oxycodone prescribing and supply need to be evaluated. We explored the impact of pharmacist-assisted discharge prescribing and medication review on oxycodone prescribing and supply for patients discharged from surgical wards.
A retrospective audit was conducted on two surgical inpatient wards following a 16-week prospective pre- and post-intervention study. During the pre-intervention period, discharge prescriptions were prepared by hospital doctors and then reviewed by a ward pharmacist (WP) before being dispensed. Post-intervention, prescriptions were prepared by a project pharmacist in consultation with hospital doctors and then reviewed by a WP and dispensed.
Proportion of patients who were prescribed, and proportion supplied, oxycodone on discharge; Median amount (milligrams) of oxycodone prescribed and supplied, for patients who were prescribed and supplied at least one oxycodone-containing preparation, respectively.
A total of 320 and 341 patients were evaluated pre- and post-intervention, respectively. Pre-intervention, 75.6% of patients were prescribed oxycodone; after WP review, 60.3% were supplied oxycodone (P<.01); the median amount both prescribed and supplied was 100 milligrams/patient. Post-intervention, 68.6% of patients were prescribed oxycodone; after WP review, 57.8% were supplied oxycodone (P<.01); median amount prescribed and supplied was 50 milligrams/patient (difference in amount prescribed and supplied: 50 milligrams, P<.01).
WP review of doctor-prepared prescriptions reduced the proportion of patients who were supplied oxycodone but not the amount supplied/patient. Having a pharmacist assist with prescribing reduced the amount of oxycodone supplied.
羟考酮的过度处方是导致处方类阿片药物滥用及死亡流行的一个因素。需要对优化羟考酮处方及供应的实践模式进行评估。我们探讨了药师协助出院处方开具及用药审查对外科病房出院患者羟考酮处方开具及供应的影响。
在进行了为期16周的前瞻性干预前和干预后研究后,对两个外科住院病房进行了回顾性审计。在干预前期,出院处方由医院医生开具,然后由病房药师(WP)在配药前进行审查。干预后,处方由项目药师与医院医生协商开具,然后由WP审查并配药。
出院时开具羟考酮的患者比例以及获得羟考酮供应的患者比例;分别针对开具并获得至少一种含羟考酮制剂的患者,所开具和供应的羟考酮的中位数剂量(毫克)。
干预前和干预后分别评估了320例和341例患者。干预前,75.6%的患者开具了羟考酮;经WP审查后,60.3%的患者获得了羟考酮供应(P<0.01);开具和供应的中位数剂量均为100毫克/患者。干预后,68.6%的患者开具了羟考酮;经WP审查后,57.8%的患者获得了羟考酮供应(P<0.01);开具和供应的中位数剂量为50毫克/患者(开具和供应剂量的差异:50毫克,P<0.01)。
WP对医生开具的处方进行审查降低了获得羟考酮供应的患者比例,但未降低每个患者的供应剂量。由药师协助开具处方减少了羟考酮的供应剂量。